Add BrightSurf on Google Email

Study rewrites the rules of the blood-brain barrier

Gladstone researchers create atlas of proteins transported across blood-brain barrier, revealing its role in delivering beneficial proteins to brain cells. The study suggests that increasing supply of protective proteins like APOA1 can counter signs of Alzheimer's disease, offering new potential treatment strategies.

SourceGladstone Institutes·JournalCell·DateNov 11, 2026

Astrocytes help sustain brain activity and blood flow during prolonged sensory stimulation

A research team identified a signaling pathway involving AQP4, TRPA1, BEST1, and D-serine that helps maintain neuronal activity and cerebral blood-volume responses during prolonged sensory stimulation. Astrocytes release D-serine, which supports neuronal activity and contributes to dilation of brain blood vessels.

SourceInstitute for Basic Science·JournalAdvanced Science·TypeExperimental study·DateNov 4, 2026

A rare case of Parkinson's disease reveals molecular changes in platelets during disease progression

A rare case of early-onset Parkinson's disease reveals molecular changes in platelets associated with disease progression. The study identified changes in gene expression in platelets, including those involved in mitochondrial function and protein synthesis, providing insights into molecular processes involved in disease progression.

SourceGermans Trias i Pujol Research Institute·JournalMovement Disorders·TypeCase study·DateOct 30, 2026

Maladaptive brain-state locking as a lifespan framework for neurodevelopmental, psychiatric, and neurodegenerative disorders

Maladaptive brain-state locking (MBSL) is a lifespan hypothesis suggesting that distinct disorders converge on impaired state-transition or recovery dynamics. Candidate features include abnormal persistence, impaired transition, and delayed recovery, with lifespan timing and regional context modifying phenotypic expression.

SourceXia & He Publishing Inc.·JournalExploratory Research and Hypothesis in Medicine·DateOct 21, 2026

Study advances mechanistic insight into tuberculosis vaccine’s link to reduced dementia risk

Researchers found that mice genetically engineered to have dementia symptoms who received BCG vaccine showed reduced neurofibrillary tangles, sustained immune cell activation, and memory loss compared to untreated mice. BCG vaccination was also linked to reduced inflammation and improved cognitive function in the mice.

SourceJohns Hopkins Medicine·JournalScience Advances·TypeExperimental study·DateOct 21, 2026

Who gets Alzheimer’s drugs? Race, vulnerability and health status shape access

A new study found significant disparities in access to anti-amyloid Alzheimer's treatments, with Black adults and Hispanic adults having lower odds of receiving the medication. However, once treatment began, patients were equally likely to take the medication as prescribed, regardless of their race or ethnicity.

SourceMichigan Medicine - University of Michigan·JournalNeurology·TypeObservational study·DateOct 15, 2026

Researchers restore neuron function in mice with Alzheimer's disease

Researchers have successfully restored the function of neurons linked to cognitive function and information processing in mice with Alzheimer's disease, a breakthrough that could lead to the development of a targeted therapy. The study, published in Neuron, reveals that manipulating parvalbumin interneurons can increase gamma oscillati...

New drug-delivery method offers promise in fight against neurodegenerative diseases

Researchers have developed a new method to deliver disease-fighting antibodies directly to the brain, using extracellular vesicles to bypass the blood-brain barrier. This approach shows potential in treating neurodegenerative diseases such as Alzheimer's, Parkinson's, and ALS, by improving the elimination of pathological proteins.

SourceUniversity of Ottawa·JournalNature Biomedical Engineering·TypeRandomized controlled/clinical trial·DateOct 15, 2026

Small-molecule therapy for Alzheimer’s disease shows promise in mice and an early clinical trial

A new small molecule therapy targets the brain's microglia cells to protect neurons, reducing markers of neuronal damage and inflammatory signaling. The therapy, VG-3927, is well-tolerated and penetrates the central nervous system, reducing levels of a marker of TREM2 in patients with Alzheimer's disease.

SourceAmerican Association for the Advancement of Science (AAAS)·JournalScience Translational Medicine·DateOct 14, 2026

Large global study examines Alzheimer’s blood biomarker across racial and ethnic groups

A large global study of 15,612 adults found that blood biomarker levels varied across racial and ethnic groups, but the relationship between biomarker levels and brain amyloid was generally consistent. The study's findings support the use of blood-based biomarkers to screen for elevated brain amyloid in preclinical Alzheimer's disease ...

SourceKeck School of Medicine of USC·JournalJAMA Neurology·TypeData/statistical analysis·DateOct 12, 2026

Brain immune cells protect neurons in Parkinson’s disease by “nibbling” harmful material

Researchers have found a new mechanism by which brain immune cells, microglia, protect neurons from Parkinson's disease by removing harmful alpha-synuclein clumps. The study identified a population of activated microglia that can selectively remove pathological protein material from neurons, suggesting a potential therapeutic target fo...

SourceUniversity of Oxford·JournalScience Translational Medicine·TypeExperimental study·DateOct 7, 2026

New study reveals timing of brain surgery is crucial for preserving memory and thinking in genetically defined Parkinson’s patients

A new study found that the timing of Deep Brain Stimulation (DBS) surgery is critical for preserving cognitive function in Parkinson’s disease patients with a specific genetic mutation. Performing DBS within the first seven to eight years of diagnosis delays significant cognitive decline, while early intervention optimizes physical mob...

SourceHackensack Meridian Health·JournalMovement Disorders·TypeObservational study·DateOct 6, 2026

Engineers develop a smart shoe that could help track changes in how people walk

Rutgers engineers have developed a smart shoe that automatically analyzes how a person walks, tracking movement and calories burned with 95.4% accuracy. The prototype powers the analysis with energy generated from the wearer's footsteps, offering a potential solution to the 'energy-intelligence bottleneck' in existing health wearables.

SourceRutgers University·JournalScience Advances·TypeData/statistical analysis·DateSep 28, 2026

ILC2 cells emerge as key cellular interfaces bridging nervous and immune systems

Group 2 innate lymphoid cells (ILC2s) form tight anatomical associations with sensory, autonomic, and enteric nerve fibers, receiving neural regulation through activating and inhibitory pathways. ILC2s also secrete cytokines that can act back on neurons, forming positive feedback loops that modulate allergic and anti-infective immunity.

SourceImmunity & Inflammation·JournalImmunity & Inflammation·TypeSystematic review·DateSep 25, 2026

People with dementia want to participate in research: Novel Law Clinic Study was found to be meaningful and empowering

A novel research approach, the Law Clinic Study, allows people with dementia to contribute to knowledge, increasing societal understanding and improving future situations. Participants valued being heard and contributing to research, challenging stereotypes that people with dementia are unable to participate.

SourceUniversity of Eastern Finland·JournalJournal of Alzheimer’s Disease·DateSep 23, 2026

Modeling childhood epilepsy in brain organoids points to possible treatments

A new study by UC Berkeley researchers suggests that hyperreactive astrocytes are a primary driver of childhood epilepsy, particularly in the inherited disorder tuberous sclerosis complex. The findings highlight possible therapies to reduce inflammation and alleviate seizures, challenging the traditional view that neurons are the sole ...

SourceUniversity of California - Berkeley·JournalNature·TypeExperimental study·DateSep 23, 2026

Nine studies led by Mount Sinai investigators featured in coordinated collection of papers that map the molecular and cellular architecture of brain disorders

Researchers identified shared and disease-specific molecular changes in human brain tissue, contributing to neurodegeneration, psychiatric illness, and cognitive decline. The collection establishes a foundational resource for understanding brain disorders, accelerating discovery and therapy development.

SourceThe Mount Sinai Hospital / Mount Sinai School of Medicine·JournalNature·TypeObservational study·DateSep 23, 2026

Study identifies increased levels of meprin-β in the brain and cerebrospinal fluid of people with Alzheimer’s disease

Researchers identify elevated levels of meprin-β in brain and cerebrospinal fluid of people with Alzheimer's disease, particularly in advanced stages. This finding suggests a possible relationship between meprin-β and beta-amyloid accumulation, a hallmark of the disease.

SourceUniversidad Miguel Hernandez de Elche·JournalAlzheimer s Research & Therapy·TypeExperimental study·DateSep 21, 2026

Microproteins provide new playbook for Alzheimer’s research

Scientists at Salk Institute create first microprotein atlas of human frontal cortex with and without Alzheimer's disease, identifying 1,067 new microproteins and a potential link to immune cell dysfunction in Alzheimer's. The atlas provides a system for investigating microproteins in aging and neurodegeneration, bringing scientists cl...

SourceSalk Institute·JournalNature Aging·DateSep 14, 2026

JMIR news: Shadow AI, vocal biomarker tech, griefbots, and a prescription video game

Researchers explore the potential of shadow AI in healthcare, voice analysis for early disease detection, and digital resurrection technologies for bereavement. A recent FDA approval also highlights the therapeutic benefits of video games for ADHD treatment, with potential for personalization and immersion in the future.

SourceJMIR Publications·JournalJournal of Medical Internet Research·TypeCommentary/editorial·DateSep 11, 2026

A new Stowers Institute brain atlas shows neurons don’t inherit their identity — they build it in their first hours of life

A new brain atlas reveals that neurons build their identity in the first hours of life, rather than inheriting it from their parent cells. The atlas, which mapped nearly 250,000 fly brain cells, shows that neuronal identity is established through a flexible, modular system involving different DNA switches and regulatory proteins.

SourceStowers Institute for Medical Research·JournalProceedings of the National Academy of Sciences·DateSep 10, 2026

Aging blocks the retina's ability to regrow lost neurons, a first-of-its-kind Upstate study finds

A new study found that aging significantly limits the ability of support cells in the retina to be reprogrammed into new neurons, a discovery that has important implications for the future of regenerative medicine. The study, published in the Proceedings of the National Academy of Sciences, also found that inflammation and decreased ce...

SourceState University of New York Upstate Medical University·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateSep 10, 2026